128 related articles for article (PubMed ID: 1103241)
1. [Prevention of hyperacute active rejection of renal allografts in primates using F(ab')2 and adequate immunosuppression].
Martins AC; Wren SF; Busch GJ; MacPherson SG; von Haefen U; Wilson RE
AMB Rev Assoc Med Bras; 1975 Sep; 21(9):259-64. PubMed ID: 1103241
[No Abstract] [Full Text] [Related]
2. Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
Wren SF; Martins AC; Von Haefen U; Busch GJ; Katske GE; Koppenheffer TL; Shaipanich T; Wilson RE
Surgery; 1974 Jul; 76(1):112-20. PubMed ID: 4135410
[No Abstract] [Full Text] [Related]
3. Control of humoral rejection of renal allografts in presensitized monkeys by monospecific F(ab')2 fragments.
Kahan MG; Martins AC; Macpherson SG; Wren SF; Busch GJ; Wilson RE
Surg Forum; 1975; 26():311-3. PubMed ID: 814638
[No Abstract] [Full Text] [Related]
4. A clinical attempt to avoid hyperacute rejection by F (ab') 2 organ pretreatment.
Ahlmén J; Gustafsson A; Claes G; Kaijser B; Svalander C; Gelin L
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):51-2. PubMed ID: 781817
[TBL] [Abstract][Full Text] [Related]
5. Survival of canine renal allografts after treatment with polyspecific F(ab')2 fragments.
Abouna GM; Garver FA; Kogure H; DeLong TG; Andres GA
Surg Forum; 1973; 24():318-20. PubMed ID: 4618655
[No Abstract] [Full Text] [Related]
6. The renal xenograft rejection. Effect of hyperimmune F(ab') 2 and succinylated IgG.
Habal MB; Misra MK; Busch GJ; Carpenter CB; Birtch AG
Transplantation; 1972 Dec; 14(6):796-8. PubMed ID: 4566275
[No Abstract] [Full Text] [Related]
7. Hyperacute and acute fulminating rejection of human renal allografts.
Williams GM; Sterioff S; Bias W
Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
[No Abstract] [Full Text] [Related]
8. Prednisone used as treatment for rejection correlates with poor outcome.
Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
[No Abstract] [Full Text] [Related]
9. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
Habal MB; Carpenter CB; Kobayashi K; Bush GJ; Misra M; Birtch AG
Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
[No Abstract] [Full Text] [Related]
10. Recurrent glomerulonephritis due to anti-glomerular basement membrane-antibodies in two successive allografts.
Beleil OM; Coburn JW; Shinaberger JH; Glassock RJ
Clin Nephrol; 1973; 1(6):377-80. PubMed ID: 4594999
[No Abstract] [Full Text] [Related]
11. Preliminary results with passive enhancement in human kidney transplantation.
Solheim BG; Flatmark A; Thorsby E
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):53-8. PubMed ID: 781818
[TBL] [Abstract][Full Text] [Related]
12. Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment.
Corman JL; Kashiwagi N; Porter KA; Andres G; Iwatsuki S; Putnam CW; Popovtzer M; Penn I; Starzl TE
Transplantation; 1973 Jul; 16(1):60-3. PubMed ID: 4576857
[No Abstract] [Full Text] [Related]
13. Renal transplantation between histocompatible donor-recipient pairs.
Seigler HF; Stickel DL; Gunnells JC; McCoy R; Ward FE; Anderson EE; Amos DB
Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
[No Abstract] [Full Text] [Related]
14. Renal transplantation between 33 HL-A-identical siblings.
Descamps B; Hinglais N; Crosnier J
Transplant Proc; 1973 Mar; 5(1):231-6. PubMed ID: 4266652
[No Abstract] [Full Text] [Related]
15. Reactivation of latent cytomegalovirus in allografts: comparison of lung graft and kidney graft in rats.
Yagyu K; Takeshita M; Otsuka T; Kubota H; Furuse A; van Breda Vriesman PJ
Transplant Proc; 1994 Aug; 26(4):2343-4. PubMed ID: 8066768
[No Abstract] [Full Text] [Related]
16. Abrogation of hyperacute rejection of renal allografts by pepsin digest fragments of antidonor antibody.
Holter AR; McKearn TJ; Neu MR; Stuart FP
Surg Forum; 1972; 23(0):280-1. PubMed ID: 4601088
[No Abstract] [Full Text] [Related]
17. Management of immunosuppressive problems in renal allograft recipients.
Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
Transplant Proc; 1987 Feb; 19(1 Pt 3):1951-4. PubMed ID: 3547899
[No Abstract] [Full Text] [Related]
18. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
[No Abstract] [Full Text] [Related]
19. New perspectives on pathogenesis and treatment of rejection in kidney transplantation.
Merrill JP
Kidney Int Suppl; 1975 Feb; (3):318-22. PubMed ID: 1099311
[No Abstract] [Full Text] [Related]
20. Abrogation of hyperacute rejection of renal allografts by pepsin digest fragments of antidonor antibody.
Holter AR; Neu MR; McKearn TJ; Lynch AF; Stuart FP
Transplant Proc; 1973 Mar; 5(1):593-6. PubMed ID: 4121180
[No Abstract] [Full Text] [Related]
[Next] [New Search]
